PLX
Protalix Biotherapeutics Inc
2.70$
-0.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 91.0% | 93.8% | 72.3% | 86.9% | 80.6% | 62.9% | 64.2% | 45.1% | 15.5% | 8.4% | 19.6% | 22.0% | 22.5% | 16.6% | 15.8% | 16.7% | 26.6% | 14.1% | 42.1% | 73.6% | 30.7% | 36.8% | 37.5% | 46.7% | 49.9% | 27.8% | 32.2% | 17.5% | 47.3% | 84.5% | 69.4% | 70.2% | 46.6% | 21.3% | 80.9% | 37.5% | 46.6% | 50.6% | 12.2% | 39.0% | 30.8% | |
| 9.0% | 6.2% | 27.7% | 13.1% | 19.4% | 37.1% | 35.8% | -3.7% | 84.5% | 91.6% | 80.4% | 78.0% | 77.5% | 83.4% | 84.2% | 83.3% | 73.4% | 85.9% | 57.9% | 26.4% | 69.3% | 63.2% | 62.5% | 53.3% | 50.1% | 72.2% | 67.8% | 82.5% | 52.7% | 15.5% | 30.6% | 29.8% | 53.4% | 78.7% | 19.1% | 62.5% | 53.4% | 49.4% | 87.8% | 61.0% | 69.2% | |
| 108.3% | 274.3% | 160.2% | 138.8% | 84.9% | 364.1% | 141.5% | 149.7% | 81.6% | 36.9% | 112.1% | 108.8% | 70.2% | 54.0% | 47.8% | 83.8% | 71.3% | 56.2% | 62.9% | 119.6% | 60.4% | 89.4% | 54.5% | 86.6% | 52.1% | 65.2% | 61.0% | 12.8% | 35.5% | 29.6% | 77.0% | 22.0% | 16.7% | 22.6% | 34.4% | 38.3% | 25.0% | 61.8% | 16.1% | 21.9% | 24.7% | |
| 43.1% | 150.9% | 87.8% | 44.3% | 37.7% | 135.4% | 55.8% | 3.1% | 16.0% | 9.4% | 12.5% | 11.1% | 17.8% | 33.6% | 8.5% | 13.3% | 4.4% | 0.1% | 12.1% | 1.1% | 12.9% | 40.5% | 36.5% | 8.8% | 42.1% | 257.6% | 20.3% | 31.5% | 62.8% | 185.9% | 15.0% | 72.9% | 84.9% | 86.8% | 25.7% | 16.8% | 16.4% | 38.7% | 12.9% | 15.6% | 17.3% | |
| 151.4% | 425.2% | 248.0% | 183.1% | 122.6% | 499.5% | 196.4% | 194.3% | 109.0% | 48.8% | 133.4% | 125.7% | 88.3% | 71.0% | 62.5% | 103.8% | 97.3% | 71.3% | 90.6% | 169.0% | 84.9% | 129.9% | 74.1% | 116.4% | 72.2% | 101.1% | 93.5% | 24.3% | 70.9% | 69.1% | 160.1% | 47.8% | 31.1% | 39.1% | 60.1% | 55.0% | 41.4% | 100.4% | 25.1% | 37.5% | 40.3% | |
| -142.4% | -419.0% | -220.3% | -169.9% | -103.2% | -462.5% | -113.1% | -139.4% | -30.3% | -13.6% | -53.0% | -47.7% | -10.8% | 12.4% | 21.7% | -20.4% | -23.9% | 14.6% | -32.7% | -142.6% | -15.6% | -66.7% | -11.6% | -63.1% | -22.0% | -29.0% | -25.6% | 58.2% | -18.2% | -53.5% | -129.6% | -18.0% | 22.2% | 39.6% | -41.0% | 7.5% | 11.9% | -51.1% | 62.7% | 23.5% | 28.9% | |
| 19.5% | 382.0% | 72.2% | 47.9% | 48.9% | 160.4% | 48.8% | 37.1% | 14.7% | 6.9% | 18.4% | 15.6% | 14.4% | 11.8% | 14.9% | 17.8% | 18.3% | 12.9% | 19.0% | 34.3% | 20.0% | 10.6% | 3.8% | 7.1% | 4.5% | 7.5% | 6.8% | 3.7% | 4.4% | 7.4% | 10.4% | 2.7% | 1.7% | 0.0% | 0.1% | 5.0% | 1.0% | 4.2% | 0.6% | 2.5% | 1.6% | |
| -156.1% | -126.1% | -2,047.4% | 7.1% | -152.0% | -613.2% | -206.5% | -174.9% | -43.1% | -20.1% | -69.6% | -63.2% | -25.0% | 1.6% | 7.7% | -37.8% | -41.1% | 2.0% | -48.4% | -174.9% | -34.8% | -78.0% | -14.2% | -60.9% | -25.1% | -37.3% | -30.6% | 56.0% | -16.6% | -61.3% | -126.3% | -16.9% | 21.4% | 40.2% | -36.9% | 4.2% | 12.5% | -52.4% | 62.6% | 24.4% | 29.1% | |
| 5.7% | -9.1% | 72.2% | 47.9% | 0.1% | 37.1% | 2.9% | 1.6% | 1.9% | 0.4% | 1.8% | 0.0% | 0.2% | 1.0% | 0.9% | 0.3% | 1.1% | -1.1% | 19.5% | 2.0% | 0.8% | 10.6% | 2.6% | -2.2% | 3.1% | 6.2% | 2.0% | 0.9% | 1.3% | -3.6% | -3.7% | -0.5% | 3.4% | 4.5% | -1.1% | 3.2% | -0.6% | 8.0% | 8.4% | 5.4% | 5.6% | |
| -156.1% | -126.1% | -2,047.4% | 7.1% | -152.0% | -613.2% | -159.0% | -174.9% | -43.1% | 36.2% | -69.6% | -63.2% | -25.0% | 1.6% | 7.7% | -37.8% | -41.1% | 2.0% | -48.4% | -174.9% | -34.8% | -78.0% | -14.2% | -60.9% | -25.1% | -43.4% | -32.7% | 55.1% | -17.9% | -57.6% | -122.6% | -16.4% | 18.0% | 35.6% | -35.8% | 1.0% | 13.2% | -60.3% | 54.3% | 19.0% | 23.5% | |
| -126.3% | -395.3% | -1,958.1% | 62.7% | -96.8% | -505.2% | -100.8% | -129.2% | -25.1% | 44.6% | -47.3% | -44.6% | -7.6% | 15.7% | 24.4% | -17.0% | -20.0% | 16.5% | -26.8% | -136.1% | -12.5% | -54.6% | -8.7% | -50.8% | -18.7% | -26.5% | -20.9% | 60.6% | -9.2% | -50.9% | -107.3% | -11.8% | 24.9% | 42.0% | -33.4% | 11.5% | 15.6% | -43.9% | 64.4% | 29.0% | 32.6% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.